Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/23/2026

Management of Hip Prosthesis Pain

Initial Pharmacologic Management

  • The American College of Physicians recommends initiating acetaminophen plus NSAIDs or COX-2 selective inhibitors as first-line therapy, representing Grade A evidence for musculoskeletal pain management in the prosthetic hip 1, 2
  • Acetaminophen should be dosed at 1g every 6 hours, not exceeding 4g daily, and used cautiously in liver disease 2
  • NSAIDs should be continued regularly for optimal anti-inflammatory effect, not just as-needed dosing 1
  • Opioids carry a Grade D recommendation and should be reserved strictly for rescue analgesia only, never scheduled dosing 1, 2

Physical Therapy and Rehabilitation

  • The American Academy of Orthopaedic Surgeons supports either formal physical therapy or unsupervised home exercise after total hip arthroplasty, with high quality evidence and moderate strength of recommendation 3
  • Early mobilization should be facilitated by optimal multimodal analgesia 4

Interventional Considerations

  • Fascia iliaca block or local infiltration analgesia may be considered for persistent pain when contraindications to basic analgesics exist or in patients with high expected pain levels 2
  • Avoid femoral nerve blocks, lumbar plexus blocks, or epidural analgesia for chronic hip prosthesis pain due to adverse effects outweighing benefits 1, 4

Critical Pitfalls to Avoid

  • Do not assume treatment failure without proper medication optimization: multimodal analgesia with scheduled acetaminophen and NSAIDs should minimize or eliminate opioid requirements 1
  • NSAIDs should be avoided in patients with colon or rectal anastomoses due to potential correlation with dehiscence 2
  • Gabapentinoids should not be used routinely for hip arthroplasty due to potential side effects without proven benefit 2

Post‑Operative Pain Management after Total Hip Arthroplasty

Analgesic Strategy

  • Scheduled non‑opioid multimodal analgesia is the cornerstone of pain control at two weeks after total hip arthroplasty, superseding rescue‑only medication regimens. 5

  • Adding or continuing a COX‑2‑selective inhibitor or a non‑steroidal anti‑inflammatory drug on a scheduled basis provides optimal anti‑inflammatory effect and improves pain control. 5

Opioid Use Recommendations

  • Opioids receive a Grade D recommendation and should be reserved strictly for breakthrough (rescue) analgesia; scheduled opioid dosing offers no additional pain relief and markedly increases adverse effects. 5

Approach‑Specific Pain Expectations

  • Pain persisting at two weeks after a posterior surgical approach is expected and can be effectively managed with appropriate multimodal analgesia; it should not be interpreted as surgical failure. 5